JOHN A. ROSS, District Judge.
This matter is before the Court on Plaintiffs' Motion to Compel Defendant Express Scripts, Inc., to Produce Documents (Doc. No. 235), Defendant Express Scripts, Inc.'s Motion for Reconsideration (Doc. No. 236), and Plaintiffs' Motion for Relief Pursuant to Rule 56(d) (Doc. No. 259). The motions are fully briefed and ready for disposition.
On August 18, 2015, approximately one month after the Court denied in part Express Scripts' motion to dismiss Plaintiffs' first amended complaint, and one week before the Rule 16 conference scheduled for August 26, 2015, Express Scripts filed a motion for partial summary judgment raising a single issue, i.e., whether it had a contractual right to terminate Plaintiff from its pharmacy provider network. (Doc. No. 192) The parties appeared for the Rule 16 conference on August 26, 2015, but were unable to agree on the scheduling and scope of discovery. The Court ordered the parties to submit proposed scheduling plans for discovery to the Court. On September 3, 2015, after reviewing the parties' submissions, the Court stayed briefing on Express Scripts' motion for partial summary judgment and granted the parties 90 days to conduct phased discovery as it related to the issues raised in Express Scripts' motion. (Doc. No. 208) At that time the Court indicated that no third party discovery would be allowed without further order of the Court. The parties stipulated and agreed to a protective order, which the Court so ordered on October 16, 2015. (Doc. No. 210)
On November 18, 2015, Plaintiffs' counsel moved to withdraw and requested the Court stay discovery and all pending deadlines for 60 days to allow Plaintiffs time to retain new counsel. (Doc. No. 211) The Court granted counsel's motion to withdraw and stayed discovery and all pending deadlines for 30 days, up to and including December 18, 2015. (Doc. No. 215) New counsel filed notices of appearance on behalf of Plaintiffs on December 3, 2015 and requested the Court lift the stay of discovery. The Court granted Plaintiffs' request on December 8, 2015 (Doc. No. 224) and subsequently extended the initial discovery deadline until February 26, 2016 and the stay on briefing on Express Scripts' pending motion for partial summary judgment until March 28, 2016 (Doc. No. 227).
On February 12, 2016, Plaintiffs filed a motion to compel Express Scripts to produce documents. (Doc. No. 235) In support of their motion, Plaintiffs argue that each of their document requests seeks "particularized information relating to Express Scripts' decision making process and the intent behind the decision to exclude over 1,000 ingredients found in compound medications and otherwise limit reimbursement to pharmacies for patients' use of compounding medications." (Doc. No. 235 at 8) Plaintiffs contend these documents directly relate to their opposition of Express Scripts' claims on summary judgment.
On February 17, 2016, Express Scripts filed a motion for reconsideration of the Court's order denying its motion to dismiss. (Doc. No. 236) Express Scripts argues that in the current complaint, Plaintiffs intentionally altered a letter sent to patients so they could allege the letter came from Express Scripts when in fact the letter came from one of Express Scripts' clients, a health plan. Plaintiffs allege the letter is evidence of parallel conduct with other pharmacy benefit managers to disseminate false and misleading information to patients regarding compounded drugs. Express Scripts asks the Court to vacate its order denying Express Scripts' motion to dismiss and require re-briefing with the true and correct client letter in the complaint. (Doc. No. 238 at 1-2)
Plaintiffs filed a motion for relief pursuant to Rule 56(d) on March 3, 2016 asking the Court to deny Express Scripts' motion for partial summary judgment as premature and to expand discovery to include third party discovery on all of Plaintiffs' claims. Alternatively, Plaintiffs ask the Court to indefinitely stay briefing on Express Scripts' partial summary judgment motion so the parties may continue to conduct discovery. (Doc. No. 259)
On March 24, 2016, the Court held a status conference on the record with counsel. (Doc. No. 268) Following the status conference, Plaintiffs submitted their proposed plan for completion of discovery in furtherance of their motion to compel. Specifically, Plaintiffs propose the following:
(Doc. No. 280) In response, Express Scripts argues that Plaintiffs' request is nothing more than a broad request to expand discovery, without limitation; is not responsive to this Court's order; and does not satisfy the standard for additional discovery set forth in
Following the August 26, 2015 Rule 16 conference, it was clear to the Court there was an understanding between counsel that phased discovery would proceed as it related to the issues raised in Express Scripts' motion for partial summary judgment. The primary issue raised in Express Scripts' motion is whether it had a contractual basis to terminate Plaintiff from its provider network. (
That said, after consideration of Plaintiffs' discovery plan, the Court will grant Plaintiffs' motion to compel in part. With respect to documents previously withheld by Express Scripts as non-responsive,
As for Plaintiffs' requests that Express Scripts run a new terms search on all electronic files of previously searched custodians and deponents as well as an additional 37 custodians listed on attached Exhibit B; produce responsive documents for the top 100 health plans enrolled with Express Scripts; and produce responsive documents not otherwise maintained on Express Scripts' database, i.e., other electronic files, hard copy files and custodian hard drive files,
The Court will extend the discovery deadline for thirty (30) days, up to and including
Accordingly,